<DOC>
	<DOC>NCT02832583</DOC>
	<brief_summary>The aim of this prospective study is to assess the efficacy of autologous Platelet Rich Plasma combined with Hyaluronic Acid prepared with RegenKit-BCT HA Cellular Matrix on skin rejuvenation. Thirty-one patients were included and received three PRP-AH injection sessions 4 weeks apart into the cheeks. The outcomes were assessed at baseline, 1, 3 and 6 months after the last injection session. Safety was assessed by reported adverse event analysis.</brief_summary>
	<brief_title>Autologous Platelet Rich Plasma Combined to Hyaluronic Acid Obtained With Regen-Kit BCT-HA in Aesthetic Medicine</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Patients aged over 40 years with chronological aging Completed informed consent form Pregnancy or breastfeeding Patients younger than 40 years Use of product or treatment aimed to improve skin rejuvenation over the last six months before study start, patients with known hypersensitivity to HA, patients with eczema flareup, patients with active skin disorder infection including herpes virus infection, active hepatitis or human infection virus infection. Dermatological diseases affecting the face Autoimmune disease such as Hashimoto, rheumatoid arthritis. Malignancy with or without metastatic disease Chemotherapy Anticoagulant therapy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>PRP, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation</keyword>
</DOC>